Tower Research Capital LLC (Trc) Affimed N.V. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.32 - $0.62 $9,534 - $18,473	-29,796 Reduced 72.54%	11,282 $6,000
Q3 2023 Nov 14, 2023	BUY	$0.46 - $0.65 $9,316 - $13,164	20,253 Added 97.25%	41,078 $19,000
Q2 2023 Aug 14, 2023	BUY	$0.57 - $1.08 $1,378 - $2,611	2,418 Added 13.14%	20,825 $12,000
Q1 2023 May 09, 2023	SELL	$0.66 - $1.29 $2,161 - $4,224	-3,275 Reduced 15.1%	18,407 $14,000
Q4 2022 Feb 10, 2023	SELL	$1.1 - $2.45 $21,159 - $47,128	-19,236 Reduced 47.01%	21,682 $27,000
Q3 2022 Nov 10, 2022	BUY	$1.96 - $3.32 $44,619 - $75,579	22,765 Added 125.41%	40,918 $85,000
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $23,249 - $49,776	10,242 Added 129.47%	18,153 $50,000
Q1 2022 May 12, 2022	BUY	$3.69 - $5.65 $5,719 - $8,757	1,550 Added 24.37%	7,911 $35,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $7.07 $31,495 - $41,465	-5,865 Reduced 47.97%	6,361 $35,000
Q3 2021 Nov 15, 2021	BUY	$5.54 - $7.51 $34,264 - $46,449	6,185 Added 102.38%	12,226 $76,000
Q2 2021 Aug 16, 2021	SELL	$7.78 - $11.4 $99,669 - $146,045	-12,811 Reduced 67.96%	6,041 $51,000
Q1 2021 May 17, 2021	BUY	$5.12 - $8.48 $60,037 - $99,436	11,726 Added 164.55%	18,852 $149,000
Q4 2020 Feb 16, 2021	SELL	$3.16 - $7.03 $240,182 - $534,329	-76,007 Reduced 91.43%	7,126 $41,000
Q3 2020 Nov 16, 2020	BUY	$3.26 - $4.73 $220,812 - $320,381	67,734 Added 439.86%	83,133 $282,000
Q2 2020 Aug 13, 2020	BUY	$1.58 - $4.63 $24,330 - $71,297	15,399 New	15,399 $71,000
Q4 2019 Feb 07, 2020	SELL	$2.25 - $3.07 $5,472 - $7,466	-2,432 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$2.67 - $3.65 $4,624 - $6,321	1,732 Added 247.43%	2,432 $7,000
Q2 2019 Aug 13, 2019	SELL	$2.6 - $4.21 $8,262 - $13,379	-3,178 Reduced 81.95%	700 $2,000
Q1 2019 May 14, 2019	BUY	$3.05 - $4.34 $11,827 - $16,830	3,878 New	3,878 $16,000
Q4 2018 Feb 14, 2019	SELL	$2.82 - $4.67 $10,425 - $17,264	-3,697 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$1.45 - $6.15 $1,167 - $4,950	805 Added 27.84%	3,697 $16,000
Q2 2018 Aug 15, 2018	BUY	$1.65 - $2.5 $3,795 - $5,750	2,300 Added 388.51%	2,892 $5,000
Q1 2018 May 15, 2018	BUY	$1.25 - $2.65 $740 - $1,568	592 New	592 $1,000
Q4 2017 Feb 09, 2018	SELL	$1.23 - $2.3 $1,457 - $2,725	-1,185 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.95 - $2.25 $2,310 - $2,666	1,185	1,185 $3,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

Tekla Capital Management LLC

586K
Shares

$2.04 Million
0.01% of portfolio
Act Capital Management, LLC Wayne, PA

309K
Shares

$1.07 Million
0.88% of portfolio
Telemetry Investments, L.L.C. New York, NY

200K
Shares

$696,000
0.39% of portfolio

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account